Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacodynamics of investigational treatments in combination with standard of care immune checkpoint inhibit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Melanoma | Phase 1 | Status: TERMINATED | Results posted: 2021-04-01